01 15AbbVie Corporation
01 52759182
02 52813985
03 52817629
01 15VENETOCLAX
01 3KIT
02 12TABLET
01 52030-05-26
02 52031-10-05
03 52031-11-21
Patent Expiration Date : 2030-05-26
Date Granted : 2016-06-07
Brand Name : VENCLEXTA
Patent Number : 2759182
Filing Date : 2010-05-26
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-05-26
Date Granted : 2016-06-07
Patent Expiration Date : 2030-05-26
Date Granted : 2016-06-07
Brand Name : VENCLEXTA
Patent Number : 2759182
Filing Date : 2010-05-26
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-05-26
Date Granted : 2016-06-07
Patent Expiration Date : 2030-05-26
Date Granted : 2016-06-07
Brand Name : VENCLEXTA
Patent Number : 2759182
Filing Date : 2010-05-26
Strength per Unit : 50 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-05-26
Date Granted : 2016-06-07
Patent Expiration Date : 2030-05-26
Date Granted : 2016-06-07
Brand Name : VENCLEXTA
Patent Number : 2759182
Filing Date : 2010-05-26
Strength per Unit : 10mg / 50mg / 100mg
Dosage Form : KIT
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-05-26
Date Granted : 2016-06-07
Patent Expiration Date : 2030-05-26
Date Granted : 2016-06-07
Brand Name : VENCLEXTA
Patent Number : 2759182
Filing Date : 2010-05-26
Strength per Unit : 10mg / 50mg / 100mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-05-26
Date Granted : 2016-06-07
Patent Expiration Date : 2031-10-05
Date Granted : 2019-01-15
Brand Name : VENCLEXTA
Patent Number : 2813985
Filing Date : 2011-10-05
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-10-05
Date Granted : 2019-01-15
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-10-05
Date Granted : 2019-01-15
Brand Name : VENCLEXTA
Patent Number : 2813985
Filing Date : 2011-10-05
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-10-05
Date Granted : 2019-01-15
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-11-21
Date Granted : 2019-08-13
Brand Name : VENCLEXTA
Patent Number : 2817629
Filing Date : 2011-11-21
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-11-21
Date Granted : 2019-08-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-10-05
Date Granted : 2019-01-15
Brand Name : VENCLEXTA
Patent Number : 2813985
Filing Date : 2011-10-05
Strength per Unit : 50 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-10-05
Date Granted : 2019-01-15
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-11-21
Date Granted : 2019-08-13
Brand Name : VENCLEXTA
Patent Number : 2817629
Filing Date : 2011-11-21
Strength per Unit : 50 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-11-21
Date Granted : 2019-08-13
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
